|
Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett’s esophagus.
Zhang HY, Zhang X, Chen X, Thomas D, Hormi-Carver K, Elder F, Spechler SJ, Souza RF.
Am J Physiol Gastrointest Liver Physiol. 2008 Sep;295(3):G470-8. Epub 2008 Jul 10.
2: Mechanisms of oxidant production in esophageal squamous cell and Barrett’s cell lines.
Feagins LA, Zhang HY, Zhang X, Hormi-Carver K, Thomas T, Terada LS, Spechler SJ, Souza RF.
Am J Physiol Gastrointest Liver Physiol. 2008 Feb;294(2):G411-7. Epub 2007 Dec 6.
3: In non-neoplastic Barrett’s epithelial cells, acid exerts early antiproliferative effects through activation of the Chk2 pathway.
Zhang HY, Zhang X, Hormi-Carver K, Feagins LA, Spechler SJ, Souza RF.
Cancer Res. 2007 Sep 15;67(18):8580-7.
4: Characterization of telomerase-immortalized, non-neoplastic, human Barrett’s cell line (BAR-T).
Jaiswal KR, Morales CP, Feagins LA, Gandia KG, Zhang X, Zhang HY, Hormi-Carver K, Shen Y, Elder F, Ramirez RD, Sarosi GA Jr, Spechler SJ, Souza RF.
Dis Esophagus. 2007;20(3):256-64.
5: Acid has antiproliferative effects in nonneoplastic Barrett’s epithelial cells.
Feagins LA, Zhang HY, Hormi-Carver K, Quinones MH, Thomas D, Zhang X, Terada LS, Spechler SJ, Ramirez RD, Souza RF.
Am J Gastroenterol. 2007 Jan;102(1):10-20.
6: All trans-retinoic acid induces apoptosis via p38 and caspase pathways in metaplastic Barrett’s cells.
Hormi-Carver K, Feagins LA, Spechler SJ, Souza RF.
Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G18-27. Epub 2006 Aug 24. |
